Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation-Reference-Cited by-同舟云学术

Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation

Published:2021-02 Issue:2 Volume:24 Page:102058
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Amaral Ana Claudia^ORCID,Perez-Nievas Beatriz G.,Siao Tick Chong Michael,Gonzalez-Martinez Alicia^ORCID,Argente-Escrig Herminia,Rubio-Guerra Sara,Commins Caitlin,Muftu Serra^ORCID,Eftekharzadeh Bahareh,Hudry Eloise,Fan Zhanyun,Ramanan Prianca,Takeda Shuko,Frosch Matthew P.,Wegmann Susanne,Gomez-Isla Teresa

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference82 articles.

1. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation);Arvanitakis;Parkinsonism Relat. Disord.,2007

2. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease;Augustinack;Acta Neuropathol.,2002

3. Role of tau protein in both physiological and pathological conditions;Avila;Physiol. Rev.,2004

4. Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits;de Barreda;Neurobiol. Dis.,2010

5. The conundrum of GSK3 inhibitors: is it the dawn of a new beginning?;Bhat;J. Alzheimers Dis.,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous tau released from humanReNCell VMcultures by neuronal activity is phosphorylated at multiple sites;2024-06-02

2. Mitochondria in Alzheimer’s Disease Pathogenesis;Life;2024-01-30

3. GSK3β phosphorylation catalyzes the aggregation of Tau into Alzheimer’s disease-like amyloid strain;2023-12-19

4. Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer’s Disease;Biology;2023-11-20

5. Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2023-11-07